Your browser doesn't support javascript.
loading
SERPINE1: A Molecular Switch in the Proliferation-Migration Dichotomy in Wound-"Activated" Keratinocytes.
Simone, Tessa M; Higgins, Craig E; Czekay, Ralf-Peter; Law, Brian K; Higgins, Stephen P; Archambeault, Jaclyn; Kutz, Stacie M; Higgins, Paul J.
Afiliação
  • Simone TM; Center for Cell Biology and Cancer Research , Albany Medical College, Albany, New York.
  • Higgins CE; Center for Cell Biology and Cancer Research , Albany Medical College, Albany, New York.
  • Czekay RP; Center for Cell Biology and Cancer Research , Albany Medical College, Albany, New York.
  • Law BK; Department of Pharmacology and Therapeutics, University of Florida , Gainesville, Florida.
  • Higgins SP; Center for Cell Biology and Cancer Research , Albany Medical College, Albany, New York.
  • Archambeault J; Center for Cell Biology and Cancer Research , Albany Medical College, Albany, New York.
  • Kutz SM; Department of Biology, Sage College of Albany , Albany, New York.
  • Higgins PJ; Center for Cell Biology and Cancer Research , Albany Medical College, Albany, New York.
Adv Wound Care (New Rochelle) ; 3(3): 281-290, 2014 Mar 01.
Article em En | MEDLINE | ID: mdl-24669362
ABSTRACT

Significance:

A highly interactive serine protease/plasmin/matrix metalloproteinase axis regulates stromal remodeling in the wound microenvironment. Current findings highlight the importance of stringent controls on protease expression and their topographic activities in cell proliferation, migration, and tissue homeostasis. Targeting elements in this cascading network may lead to novel therapeutic approaches for fibrotic diseases and chronic wounds. Recent Advances Matrix-active proteases and their inhibitors orchestrate wound site tissue remodeling, cell migration, and proliferation. Indeed, the serine proteases urokinase plasminogen activator and tissue-type plasminogen activator (uPA/tPA) and their major phsyiological inhibitor, plasminogen activator inhibitor-1 (PAI-1; serine protease inhibitor clade E member 1 [SERPINE1]), are upregulated in several cell types during injury repair. Coordinate expression of proteolytic enzymes and their inhibitors in the wound bed provides a mechanism for fine control of focal proteolysis to facilitate matrix restructuring and cell motility in complex environments. Critical Issues Cosmetic and tissue functional consequences of wound repair anomalies affect the quality of life of millions of patients in the United States alone. The development of novel therapeutics to manage individuals most affected by healing anomalies will likely derive from the identification of critical, translationally accessible, control elements in the wound site microenvironment. Future Directions Activation of the PAI-1 gene early after wounding, its prominence in the repair transcriptome and varied functions suggest a key role in the global cutaneous injury response program. Targeting PAI-1 gene expression and/or PAI-1 function with molecular genetic constructs, neutralizing antibodies or small molecule inhibitors may provide a novel, therapeutically relevant approach, to manage the pathophysiology of wound healing disorders associated with deficient or excessive PAI-1 levels.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article